Related Experiment Videos
Management of bisphosphonate-induced osteonecrosis of the jaw
1University of Minnesota, School of Dentistry, Department of Periodontology, Minneapolis, Minnesota, USA.
Abstract:
In conclusion, careful treatment planning minimizes BIONJ risk in patients with bisphosphonate exposure. The drug type, dose, potency, and duration are important factors in determining the cumulative effect on bone remodeling and resultant risk of BIONJ. Dentists and physicians should work closely to balance the risks of the oral and systemic conditions surrounding bisphosphonate use. A critical assessment of current literature is necessary to best serve our patients.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Osteoclasts in Bone Remodeling
Tonsillitis II: Management
Urinary Tract Calculi V: Nursing Management
Bone Remodeling